A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 01 2023
Historique:
received: 20 12 2021
accepted: 24 11 2022
pubmed: 8 1 2023
medline: 11 1 2023
entrez: 7 1 2023
Statut: epublish

Résumé

Immune checkpoint therapy in breast cancer remains restricted to triple negative patients, and long-term clinical benefit is rare. The primary aim of immune checkpoint blockade is to prevent or reverse exhausted T cell states, but T cell exhaustion in breast tumors is not well understood. Here, we use single-cell transcriptomics combined with imaging mass cytometry to systematically study immune environments of human breast tumors that either do or do not contain exhausted T cells, with a focus on luminal subtypes. We find that the presence of a PD-1

Identifiants

pubmed: 36609566
doi: 10.1038/s41467-022-35238-w
pii: 10.1038/s41467-022-35238-w
pmc: PMC9822999
doi:

Substances chimiques

Programmed Cell Death 1 Receptor 0
Antineoplastic Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

98

Informations de copyright

© 2023. The Author(s).

Références

Cancer Immunol Res. 2015 Jan;3(1):26-36
pubmed: 25127875
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Cell. 2019 Feb 7;176(4):775-789.e18
pubmed: 30595452
JAMA Oncol. 2019 Aug 01;5(8):1205-1214
pubmed: 30973611
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Anticancer Res. 2014 Mar;34(3):1355-66
pubmed: 24596383
Nat Methods. 2017 Sep;14(9):873-876
pubmed: 28783155
Mod Pathol. 2019 Jan;32(1):70-80
pubmed: 30154578
Nature. 2020 Feb;578(7796):615-620
pubmed: 31959985
BMC Genomics. 2018 Jun 19;19(1):477
pubmed: 29914354
Bioinformatics. 2019 Jan 1;35(1):28-35
pubmed: 29939207
Nature. 2019 Jul;571(7764):270-274
pubmed: 31207604
Nat Rev Immunol. 2020 Jan;20(1):7-24
pubmed: 31467405
Cancer Cell. 2018 Apr 9;33(4):547-562
pubmed: 29634943
Nat Commun. 2020 Dec 2;11(1):6175
pubmed: 33268821
Front Cell Infect Microbiol. 2020 Feb 13;10:49
pubmed: 32117816
Cell. 2018 Nov 1;175(4):998-1013.e20
pubmed: 30388456
J Clin Pathol. 2016 May;69(5):422-30
pubmed: 26475777
Nat Biotechnol. 2021 Sep;39(9):1103-1114
pubmed: 33349700
Nat Med. 2018 Jul;24(7):986-993
pubmed: 29942092
Gigascience. 2018 Jul 1;7(7):
pubmed: 30010766
Sci Immunol. 2020 Apr 17;5(46):
pubmed: 32303573
Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):E2794-802
pubmed: 23011795
Nat Methods. 2020 Feb;17(2):159-162
pubmed: 31819264
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
Nat Methods. 2014 Apr;11(4):417-22
pubmed: 24584193
EBioMedicine. 2019 Sep;47:78-88
pubmed: 31439476
Cell. 2019 Oct 31;179(4):829-845.e20
pubmed: 31675496
Front Immunol. 2017 Dec 19;8:1830
pubmed: 29312327
Nat Methods. 2017 Mar;14(3):309-315
pubmed: 28114287
Sci Immunol. 2022 Apr;7(70):eabk1692
pubmed: 35363540
Nat Methods. 2019 Dec;16(12):1226-1232
pubmed: 31570887
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
J Clin Invest. 2013 Jul;123(7):2873-92
pubmed: 23778140
Front Immunol. 2021 Feb 25;12:643692
pubmed: 33717201
Cancer Immunol Res. 2019 May;7(5):784-796
pubmed: 30872264
Nat Commun. 2018 Jul 13;9(1):2724
pubmed: 30006565
Nat Immunol. 2014 Apr;15(4):373-83
pubmed: 24584090
Cancer Immunol Immunother. 2021 Mar;70(3):607-617
pubmed: 33015734
J Exp Med. 2003 Jul 21;198(2):305-13
pubmed: 12874263
Breast Care (Basel). 2020 Oct;15(5):450-469
pubmed: 33223989
Cell. 2017 May 4;169(4):736-749.e18
pubmed: 28475899
Int J Oral Sci. 2020 Sep 15;12(1):24
pubmed: 32934197
Cell Res. 2020 Sep;30(9):745-762
pubmed: 32561858
Br J Cancer. 2021 Jan;124(2):359-367
pubmed: 32929195
Cancer Cell. 2011 Apr 12;19(4):541-55
pubmed: 21481794
Nat Med. 2021 May;27(5):820-832
pubmed: 33958794
Nat Commun. 2018 Oct 16;9(1):4297
pubmed: 30327458
Nat Methods. 2020 Feb;17(2):137-145
pubmed: 31792435
Cell Syst. 2018 Jan 24;6(1):25-36.e5
pubmed: 29289569
PLoS Biol. 2018 Jul 3;16(7):e2005970
pubmed: 29969450
Breast Cancer Res Treat. 2013 Jun;139(3):667-76
pubmed: 23756627
Oncoimmunology. 2013 Oct 1;2(10):e26066
pubmed: 24244900
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Science. 2020 Feb 21;367(6480):
pubmed: 32079746
F1000Res. 2016 Aug 31;5:2122
pubmed: 27909575
Int J Mol Sci. 2020 Jul 05;21(13):
pubmed: 32635651
Cancer Immunol Res. 2017 Jul;5(7):516-523
pubmed: 28619968
PLoS Med. 2016 Dec 13;13(12):e1002194
pubmed: 27959923
Bioinformatics. 2017 Apr 15;33(8):1179-1186
pubmed: 28088763
Cell Syst. 2019 Apr 24;8(4):329-337.e4
pubmed: 30954475
Cancer Cell. 2021 Jul 12;39(7):928-944.e6
pubmed: 33961783
Nat Rev Cancer. 2020 Apr;20(4):218-232
pubmed: 32024970
Cell. 2018 Sep 6;174(6):1373-1387.e19
pubmed: 30193111
Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8
pubmed: 34653365
FEBS Lett. 2012 Mar 23;586(6):766-71
pubmed: 22293503
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Curr Opin Immunol. 2018 Apr;51:123-132
pubmed: 29567511
Front Immunol. 2019 Oct 29;10:2534
pubmed: 31736961
Nature. 2018 Dec;564(7735):268-272
pubmed: 30479382
Nature. 2020 Apr;580(7802):257-262
pubmed: 32269339
Cell. 2019 May 16;177(5):1330-1345.e18
pubmed: 30982598
Eur Respir J. 2020 Feb 6;55(2):
pubmed: 32029641
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1625-1634
pubmed: 27672056
Clin Cancer Res. 2017 Jun 1;23(11):2640-2646
pubmed: 28572258
Eur J Immunol. 1988 Oct;18(10):1643-6
pubmed: 3263925
Crit Rev Oncol Hematol. 2019 May;137:57-83
pubmed: 31014516
BMC Cancer. 2015 Mar 06;15:101
pubmed: 25884667
Sci Rep. 2018 Jan 10;8(1):256
pubmed: 29321503
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Bioinformatics. 2020 Dec 26;:
pubmed: 33367748
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
Breast Cancer Res. 2021 Jan 7;23(1):4
pubmed: 33413541
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
J Clin Pathol. 1977 Aug;30(8):758-62
pubmed: 599189
Nat Cancer. 2020 May;1(5):546-561
pubmed: 32803172
Immunol Rev. 2003 Dec;196:7-24
pubmed: 14617194
Front Immunol. 2018 Aug 15;9:1838
pubmed: 30158927
Cancer Res. 2011 Sep 1;71(17):5678-87
pubmed: 21846823
Nat Rev Immunol. 2019 Jun;19(6):369-382
pubmed: 30718830
Nucleic Acids Res. 2020 Jun 4;48(10):e55
pubmed: 32196115
Cell Syst. 2018 May 23;6(5):612-620.e5
pubmed: 29605184
J Clin Oncol. 2018 Jun 10;36(17):1668-1674
pubmed: 29283791

Auteurs

Sandra Tietscher (S)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
Life Science Zurich Graduate School, ETH Zurich and University of Zurich, Zurich, Switzerland.

Johanna Wagner (J)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Division of Translational Medical Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.

Tobias Anzeneder (T)

Patients' Tumor Bank of Hope (PATH), Munich, Germany.

Claus Langwieder (C)

Pathology at Josefshaus, Dortmund, Germany.

Martin Rees (M)

Pathology at Josefshaus, Dortmund, Germany.

Bettina Sobottka (B)

Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Natalie de Souza (N)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland.

Bernd Bodenmiller (B)

Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland. bernd.bodenmiller@uzh.ch.
Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. bernd.bodenmiller@uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH